Endocrinology 153:57705781 Wei R, Ma S, Wang C, Ke J, Yang J, Li W, Liu Y, Hou W, Feng X, Wang G, Hong T (2016) Exenatide exerts direct protective effects on endothelial cells through the AMPK/Akt/eNOS pathway in a GLP-1 receptor-dependent manner
According to the FDA, one of the potential concerns is that the compounded drug may contain the incorrect amount of an active ingredient, leading to adverse effects
Whether you are using compounded tirzepatide or semaglutide, knowing that your medication is safe and effective allows you to move forward with confidence
Compounded medications prepared by licensed 503A pharmacies follow USP standards but are not FDA-approved products
This approach is designed to: Minimize side effects Higher doses can cause nausea, vomiting, or gastrointestinal discomfort
Citations & References 1